Product description

Fields of Application: Diabetes II Active Substance: Exendin-4 (exenatide), a 39-amino acid peptide originally isolated from the salivary glands of the Gila monster (Heloderma suspectum), differs from exendin-3 only in two positions close to the N-terminus. Application of exenatide causes an increase in acinar cAMP without stimulating amylase release. As an incretin mimetic, exenatide acts as agonist of the glucagon-like peptide-1 (GLP-1) receptor. As GLP-1, though with prolonged activity, exenatide augments the postprandial production of insulin and suppresses secretion of glucagon. For this reason, exenatide has found use as a medication of diabetes II.
Read more

Specifications

CAS Registry Number 141732-76-5
Categories APIs (Active Pharmaceutical Ingredients)
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Switzerland
Measured In piece
Selling Points Brand Name; Experienced Technicians; International Approvals/Standards; Place of Origin; Prompt Delivery; Quality Service; Reputation

More products from Bachem AG

View all our products (24)
Grifols Partnership- Contract Manufacturing Services

Grifols Partnership- Contract Manufacturing Services

Collaborating to innovate in drug formulation

Collaborating to innovate in drug formulation

API Supplier, CMO, CDMO

API Supplier, CMO, CDMO

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Curia - From Curiosity to Cure

Curia - From Curiosity to Cure